Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery
NCT03783702Phase 4Completed
- Sponsor
- Stanford University
- Start
- Apr 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of ibuprofen in postoperative pain, sponsored by Stanford University. Primary endpoint: Pain Severity (VAS) at 7 days. Started Apr 2019; status: completed.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03783702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783702.